As I’ve written before, my own glycaemia has been described by some doctors as “approaching normoglycaemia”, and my last lab HbA1c result came in at 33 mmol/mol (5.2%). I’m not going to pretend that I’m “normal” (and I’m not the example in this article) but personally I have been feeling that my BG profile has …
“Continuous” glucose monitors (CGMs) aren’t actually continual. Most take a reading every 5 minutes. But it’s easy to forget that. In any moment we see a number on our CGM display, and it feels like that’s our current BG. But it was calculated by the CGM up to 5 minutes ago, and will usually be …
To quote from Wikipedia, Segal’s Law is an adage that states: “A man with a watch knows what time it is. A man with two watches is never sure.” How is this relevant to diabetes? Well, for the last fortnight I’ve been wearing three CGMs. It’s been quite enlightening. The three systems I’ve been using have been: …
Over the years I’ve spent some time living with multiple CGM systems: Dexcom G4 and G5 Medtronic Guardian2/Enlite (640G pump) FreeStyle Libre FreeStyle Libre with Spike/xDrip+ Incidentally for the purposes of this technical discussion, the Libre is a Continuous Glucose Monitor. Any lack of alarms/etc does not change this, even if “Flash” monitoring doesn’t have …
Back in June Abbott released the LibreLink app in Australia, allowing us to scan the Libre sensors directly into phones. Currently the data read that way can’t be merged with the data read through the Reader device linked to the same sensor, but it offers another connectivity option for users. This week we’ve seen news …
The Abbott Libre “flash” glucose monitoring system has been available in Australia since June 2016. It currently costs almost $95 per fortnight, and just like the CGM systems there’s no funding subsidy available yet. But meanwhile, this week at the EASD meeting in Berlin, Abbott have announced their new “Libre 2” system. We have known …